|
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hot Products
*For Non-Clinical Research Use Only*
|
Afficher par Catégorie
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), P. Pichia Derived (Sargramostim), human
| Full Name |
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), P. Pichia Derived (Sargramostim), Human
|
Abbreviated Name-1 |
rHu GM-CSF, Sargramostim, Recombinant Human GM-CSF, Sargramostim; |
|
Description |
GM-CSF was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. It is produced by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophage progenitors, GM-CSF is also a growth factor for erythroid, megakaryocyte and eosinophil progenitors. On mature hematopoietic, monocytes/ macrophages and eosinophils. GM-CSF has also been reported to have a functional role on non-hematopoitic cells. It can induce human endothelial cells to migrate and proliferate. Additionally, GM-CSF can also stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma and adenocarcinoma cell lines.
GenScript Granulocyte Macrophage Colony Stimulating Factor P. Pichia Derived (Sargramostim), human, is a single, glycosylated polypeptide chain containing 127 amino acids and having a molecular mass of about 26,000-32,000 Da, as shown in SDS-PAGE. It differs from natural human GM-CSF by a substitution of leucine at position 23 (R to L), and the carbohydrate moiety may be different from the native protein. |
Source |
P. Pichia |
M.W. |
26,000-32,000 Da |
Purity |
The purity level of GenScript Recombinant Human GM-CSF is greater than 95.0%, as determined by the following methods:
(a) RP-HPLC anaylsis
(b) Reducing and non-reducing SDS-PAGE silver-stained gel analysis |
Endotoxin Level |
Less than 0.1 ng/µg (1 IEU/µg) of sargramostim |
Storage |
Although lyophilized GenScript Sargramostim can remain stable at room temperature for three weeks, it is best stored desiccated below -18°C. Upon reconstitution Sargramostim should be stored at 4°C between 2-7 days and for future use below -18°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles. |
Formulation |
The protein was lyophilized after extensive dialysis against 10mM Tris-HCl, pH8.5, 4% Mannitol, 1% Sucrose buffer. |
Reconstitution |
It is recommended to reconstitute the lyophilized Sargramostim in sterile 18 MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
Specificity |
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less than 0.2 ng/ml, corresponding to a specific activity of 5.0×106 IU/ mg. |
Sequence |
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Ala-Arg-Ser. |
Note |
; |
|
Document-COA: 13679_20110331050812.PDF (PDF)